Literature DB >> 28865877

Oral immunotherapy for food allergy.

Deborah M Hussey Freeland1, Monali Manohar1, Sandra Andorf1, Benjamin D Hobson2, Wenming Zhang1, Kari C Nadeau3.   

Abstract

Food allergy is a pathological, potentially deadly cascade of immune responses to molecules or molecular fragments that are normally innocuous when encountered in foods, such as milk, egg, or peanut. As the incidence and prevalence of food allergy rise, the standard of care is poised to advance beyond food allergen avoidance coupled with injectable epinephrine treatment of allergen-induced systemic reactions. Recent studies provide evidence that oral immunotherapy may effectively redirect the atopic immune responses of food allergy patients as they ingest small but gradually increasing allergen doses over many months, eliciting safer immune responses to these antigens. Research into the molecular and cellular bases of pathological and therapeutic immune responses, and into the possibilities for their safe and effective modulation, is generating tremendous interest in basic and clinical immunology. We synthesize developments, innovations, and key challenges in our understanding of the immune mechanisms associated with atopy and oral immunotherapy for food allergy.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antigen-specific; Epitope; Oral food challenge; Sustained unresponsiveness; T helper 2 cell; Tolerogenic

Mesh:

Substances:

Year:  2017        PMID: 28865877      PMCID: PMC5776738          DOI: 10.1016/j.smim.2017.08.008

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  92 in total

1.  Omalizumab treatment downregulates dendritic cell FcepsilonRI expression.

Authors:  Calman Prussin; Daniel T Griffith; Kevin M Boesel; Henry Lin; Barbara Foster; Thomas B Casale
Journal:  J Allergy Clin Immunol       Date:  2003-12       Impact factor: 10.793

2.  Blocking antibodies induced by specific allergy vaccination prevent the activation of CD4+ T cells by inhibiting serum-IgE-facilitated allergen presentation.

Authors:  R J van Neerven; T Wikborg; G Lund; B Jacobsen; A Brinch-Nielsen; J Arnved; H Ipsen
Journal:  J Immunol       Date:  1999-09-01       Impact factor: 5.422

Review 3.  Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis.

Authors:  Christoph S N Klose; David Artis
Journal:  Nat Immunol       Date:  2016-06-21       Impact factor: 25.606

4.  Mechanistic correlates of clinical responses to omalizumab in the setting of oral immunotherapy for milk allergy.

Authors:  Pamela A Frischmeyer-Guerrerio; Madhan Masilamani; Wenjuan Gu; Erica Brittain; Robert Wood; Jennifer Kim; Kari Nadeau; Kirsi M Jarvinen; Alexander Grishin; Robert Lindblad; Hugh A Sampson
Journal:  J Allergy Clin Immunol       Date:  2017-04-13       Impact factor: 10.793

5.  Regulation of IL-9 expression by IL-25 signaling.

Authors:  Pornpimon Angkasekwinai; Seon Hee Chang; Manoj Thapa; Hiroshi Watarai; Chen Dong
Journal:  Nat Immunol       Date:  2010-02-14       Impact factor: 25.606

6.  Luminal bacteria recruit CD103+ dendritic cells into the intestinal epithelium to sample bacterial antigens for presentation.

Authors:  Julia Farache; Idan Koren; Idan Milo; Irina Gurevich; Ki-Wook Kim; Ehud Zigmond; Glaucia C Furtado; Sergio A Lira; Guy Shakhar
Journal:  Immunity       Date:  2013-02-07       Impact factor: 31.745

Review 7.  Molecular and cellular mechanisms of food allergy and food tolerance.

Authors:  R Sharon Chinthrajah; Joseph D Hernandez; Scott D Boyd; Stephen J Galli; Kari C Nadeau
Journal:  J Allergy Clin Immunol       Date:  2016-04       Impact factor: 10.793

8.  TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand.

Authors:  Tomoki Ito; Yui-Hsi Wang; Omar Duramad; Toshiyuki Hori; Guy J Delespesse; Norihiko Watanabe; F Xiao-Feng Qin; Zhengbin Yao; Wei Cao; Yong-Jun Liu
Journal:  J Exp Med       Date:  2005-11-07       Impact factor: 14.307

9.  Specific immunotherapy modifies allergen-specific CD4(+) T-cell responses in an epitope-dependent manner.

Authors:  Erik Wambre; Jonathan H DeLong; Eddie A James; Nadia Torres-Chinn; Wolfgang Pfützner; Christian Möbs; Stephen R Durham; Stephen J Till; David Robinson; William W Kwok
Journal:  J Allergy Clin Immunol       Date:  2013-12-25       Impact factor: 10.793

10.  Phase 1 results of safety and tolerability in a rush oral immunotherapy protocol to multiple foods using Omalizumab.

Authors:  Philippe Bégin; Tina Dominguez; Shruti P Wilson; Liane Bacal; Anjuli Mehrotra; Bethany Kausch; Anthony Trela; Morvarid Tavassoli; Elisabeth Hoyte; Gerri O'Riordan; Alanna Blakemore; Scott Seki; Robert G Hamilton; Kari C Nadeau
Journal:  Allergy Asthma Clin Immunol       Date:  2014-02-20       Impact factor: 3.406

View more
  9 in total

1.  Fecal microbiome and metabolome differ in healthy and food-allergic twins.

Authors:  Riyue Bao; Lauren A Hesser; Ziyuan He; Xiaoying Zhou; Kari C Nadeau; Cathryn R Nagler
Journal:  J Clin Invest       Date:  2021-01-19       Impact factor: 14.808

Review 2.  Biomarkers in Food Allergy.

Authors:  Antonella Muraro; Stefania Arasi
Journal:  Curr Allergy Asthma Rep       Date:  2018-10-03       Impact factor: 4.806

Review 3.  New treatment directions in food allergy.

Authors:  Vanitha Sampath; Sayantani B Sindher; Wenming Zhang; Kari C Nadeau
Journal:  Ann Allergy Asthma Immunol       Date:  2018-03       Impact factor: 6.347

Review 4.  Molecular Approaches for Diagnosis, Therapy and Prevention of Cow´s Milk Allergy.

Authors:  Birgit Linhart; Raphaela Freidl; Olga Elisyutina; Musa Khaitov; Alexander Karaulov; Rudolf Valenta
Journal:  Nutrients       Date:  2019-06-29       Impact factor: 5.717

5.  Resistance of parvalbumin to gastrointestinal digestion is required for profound and long-lasting prophylactic oral tolerance.

Authors:  Raphaela Freidl; Antonia Gstöttner; Ulrike Baranyi; Ines Swoboda; Frank Stolz; Margarete Focke-Tejkl; Thomas Wekerle; Ronald van Ree; Rudolf Valenta; Birgit Linhart
Journal:  Allergy       Date:  2019-10-03       Impact factor: 13.146

6.  Potential Biomarkers, Risk Factors and their Associations with IgE-mediated Food Allergy in Early Life: A Narrative Review.

Authors:  Caroline E Childs; Daniel Munblit; Laurien Ulfman; Carlos Gómez-Gallego; Liisa Lehtoranta; Tobias Recker; Seppo Salminen; Machteld Tiemessen; Maria Carmen Collado
Journal:  Adv Nutr       Date:  2021-10-01       Impact factor: 8.701

7.  Oropharyngeal symptoms without systemic reactions as a risk factor for food allergen intolerance: a longitudinal pediatric study.

Authors:  Masaaki Hamada; Keigo Saeki; Yoshihiko Sakurai
Journal:  Allergy Asthma Clin Immunol       Date:  2022-04-18       Impact factor: 3.406

8.  Butyrate Enhances Desensitization Induced by Oral Immunotherapy in Cow's Milk Allergic Mice.

Authors:  Marlotte M Vonk; Bart R J Blokhuis; Mara A P Diks; Laura Wagenaar; Joost J Smit; Raymond H H Pieters; Johan Garssen; Léon M J Knippels; Betty C A M van Esch
Journal:  Mediators Inflamm       Date:  2019-01-16       Impact factor: 4.711

9.  Pharmacokinetics and Metabolism Study of Deep-Sea-Derived Butyrolactone I in Rats by UHPLC-MS/MS and UHPLC-Q-TOF-MS.

Authors:  Liang Wu; Chun-Lan Xie; Xian-Wen Yang; Gang Chen
Journal:  Mar Drugs       Date:  2021-12-22       Impact factor: 5.118

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.